( ) -q-25- UNDATED (Correspondent Jeremy House) “clots were detected.” The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled. [CutID: <Cuts> ASTRAZENECA-VACCINE-house-q-THUam.mp3 Time: 25s Title: ASTRAZENECA-VACCINE-house-q-THUam Out-cue: clots were detected] TAG: Correspondent Jeremy House reporting. Studies have since shown messenger RNA COVID vaccines to be more effective and […]
Audio
AstraZeneca pulls its COVID-19 vaccine from the European market
( ) -q-25- UNDATED (Correspondent Jeremy House) “clots were detected.”
The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled.
[CutID: <Cuts> ASTRAZENECA-VACCINE-house-q-THUam.mp3
Time: 25s
Title: ASTRAZENECA-VACCINE-house-q-THUam
Out-cue: clots were detected]
TAG: Correspondent Jeremy House reporting. Studies have since shown messenger RNA COVID vaccines to be more effective and AstraZeneca’s shot is rarely used globally.
————————————-
VERBATIM: In an update on the European Medicines Agency’s website, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn at the company’s request. AstraZeneca’s vaccine was first approved by the EMA in January 2021. But within weeks, concerns grew about the vaccine’s safety, when dozens of countries suspended the vaccine’s use after rare blood clots were detected.